The drug, chemically known as paltusotine and to be sold under the brand name Palsonify, was approved to treat acromegaly, a rare condition in which the pituitary gland in the brain produces excess growth hormone, causing the bones, organs and other tissues to grow bigger. This is caused due to a tumor on the pituitary gland.
Sign up here.
According to the U.S. National Institutes of Health, scientists estimate about 3 to 14 of every 100,000 people have been diagnosed as having acromegaly.
Reporting by Bageshri Banerjee, Sneha S K and Siddhi Mahatole in Bengaluru; Editing by Shailesh Kuber and Krishna Chandra Eluri